The clinical and economic consequences of clinically important gastro-intestinal bleeding in critically ill patients

Clinical Intensive Care

Volumn 7, Issue 3, 1996, Pages 121-125

  Heyland, D ^a   Gafni, A ^a   Griffith, L ^a   Cook, D ^a   Marshall, J ^a   Fuller, H ^a   Todd, T ^a   Guslits, B ^a   Heule, M ^a   Hewson, J ^a   Lacroix, J ^a   Noseworthy, T ^a   Powles, P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anti ulcer agents; Cost analysis; Critical care; Critical illness; Decision making; Economics; Gastro intestinal haemorrhage; Peptic ulcer haemorrhage

Indexed keywords

ANTIULCER AGENT;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANADA; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEMODYNAMICS; HOSPITAL COST; HUMAN; INTENSIVE CARE; LABORATORY TEST; LENGTH OF STAY; MALE; MORTALITY; PEPTIC ULCER;

EID: 0029740788     PISSN: 09563075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)